Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevenar13 in Children with Type 1 Diabetes
NCT01939522Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Aug 2013
- Primary completion
- Apr 2016
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal infection, sponsored by University of Oxford. Started Aug 2013; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT01939522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01939522.